中国防痨杂志 ›› 2021, Vol. 43 ›› Issue (6): 532-538.doi: 10.3969/j.issn.1000-6621.2021.06.002
收稿日期:
2021-04-26
出版日期:
2021-06-10
发布日期:
2021-06-02
基金资助:
Received:
2021-04-26
Online:
2021-06-10
Published:
2021-06-02
摘要:
卡介苗(bacillus Calmette-Guérin,BCG)是一种预防结核病的减毒活疫苗,是至今全球接种最广泛、最安全的疫苗之一。中国自1978年开始广泛接种BCG后,儿童粟粒性结核病及结核性脑膜炎的发病率和死亡率显著降低。除了应用于预防结核病外,BCG也常用于膀胱原位癌灌注治疗,采用BCG灌注可以降低和延缓非肌层浸润性膀胱癌的复发和进展,是目前公认效果最佳的膀胱灌注药品。但是由于生产工艺、疫苗毒力强弱、疫苗使用方法及个体差异等因素,BCG接种及灌注后的不良反应也时有发生。目前,BCG不良反应的临床处理尚未统一和规范。为此,中华医学会结核病学分会联合中国防痨协会学校与儿童结核病防治专业分会,组织专家进行深入讨论,制定了《卡介苗不良反应临床处理指南》。本指南介绍了BCG种类、使用方法,以及BCG不良反应的表现、诊断、治疗及预防等,以期医护人员用于规范处理BCG不良反应。
. 卡介苗不良反应临床处理指南[J]. 中国防痨杂志, 2021, 43(6): 532-538. doi: 10.3969/j.issn.1000-6621.2021.06.002
. Guideline for clinical management of adverse reactions of bacillus Calmette-Guérin[J]. Chinese Journal of Antituberculosis, 2021, 43(6): 532-538. doi: 10.3969/j.issn.1000-6621.2021.06.002
[1] |
Calmette A. Preventive vaccination against tuberculosis with BCG. Proc R Soc Med, 1931,24(11):1481-1490.
pmid: 19988326 |
[2] |
Mangtani P, Abubakar I, Ariti C, et al. Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials. Clin Infect Dis, 2014,58(4):470-480. doi: 10.1093/cid/cit790.
doi: 10.1093/cid/cit790 URL |
[3] |
World Health Organization. BCG vaccine: WHO position paper, February 2018-Recommendations. Vaccine, 2018,36(24):3408-3410. doi: 10.1016/j.vaccine.2018.03.009.
doi: S0264-410X(18)30345-1 pmid: 29609965 |
[4] | 中华人民共和国国家卫生和计划生育委员会疾病预防控制局. 国家卫生计生委办公厅关于印发国家免疫规划儿童免疫程序及说明(2016年版)的通知. 国卫办疾控发〔2016〕52号. 2016-12-06. |
[5] | 潘家国. 卡介苗接种实用手册. 南京: 东南大学出版社, 2006: 94-95. |
[6] | 吴克长. 130例BCG接种后局部异常反应原因分析. 中国热带医学, 2008,8(10):1822. |
[7] | World Health Organization. Information sheet observed rate of vaccine reactions Bacillus Calmette-Guérin (BCG) vaccine. Geneva: World Health Organization, 2012. |
[8] |
Elsidig N, Alshahrani D, Alshehri M, et al. Bacillus Calmette-Guérin vaccine related lymphadenitis in children: Management guidelines endorsed by the Saudi Pediatric Infectious Diseases Society (SPIDS). Int J Pediatr Adolesc Med, 2015,2(2):89-95. doi: 10.1016/j.ijpam.2015.05.003.
doi: 10.1016/j.ijpam.2015.05.003 URL |
[9] |
Venkataraman A, Yusuff M, Liebeschuetz S, et al. Management and outcome of Bacille Calmette-Guérin vaccine adverse reactions. Vaccine, 2015,33(41):5470-5474. doi: 10.1016/j.vaccine.2015.07.103.
doi: S0264-410X(15)01107-X pmid: 26275478 |
[10] |
Li T, Zhou X, Ling Y, et al. Genetic and Clinical Profiles of Disseminated Bacillus Calmette-Guérin Disease and Chronic Granulomatous Disease in China. Front Immunol, 2019,10:73. doi: 10.3389/fimmu.2019.00073.
doi: 10.3389/fimmu.2019.00073 URL |
[11] |
Marciano BE, Huang CY, Joshi G, et al. BCG vaccination in patients with severe combined immunodeficiency: complications, risks, and vaccination policies. J Allergy Clin Immunol, 2014,133(4):1134-1141. doi: 10.1016/j.jaci.2014.02.028.
doi: 10.1016/j.jaci.2014.02.028 URL |
[12] |
de la Morena MT, Leonard D, Torgerson TR, et al. Long-term outcomes of 176 patients with X-linked hyper-IgM syndrome treated with or without hematopoietic cell transplantation. J Allergy Clin Immunol, 2017,139(4):1282-1292. doi: 10.1016/j.jaci.2016.07.039.
doi: 10.1016/j.jaci.2016.07.039 URL |
[13] |
Bustamante J, Boisson-Dupuis S, Abel L, et al. Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-gamma immunity. Semin Immunol, 2014,26(6):454-470. doi: 10.1016/j.smim.2014.09.008.
doi: 10.1016/j.smim.2014.09.008 URL |
[14] |
卢水华, 李涛, 席秀红, 等. 播散性卡介菌病23例分析. 中华传染病杂志, 2013,31(7):417-421. doi: 10.3760/cma.j.issn.1000-6680.2013.07.009.
doi: 10.3760/cma.j.issn.1000-6680.2013.07.009 |
[15] | Aronson JK. Meyler’s Side Effects of Drugs. 16th ed. Amsterdam: Elsevier, 2016: 797-806. |
[16] |
Casanova JL, Jouanguy E, Lamhamedi S, et al. Immunological conditions of children with BCG disseminated infection. Lancet, 1995,346(8974):581. doi: 10.1016/s0140-6736(95)91421-8.
doi: 10.1016/s0140-6736(95)91421-8 pmid: 7658805 |
[17] | 赵爱华, 寇丽杰, 乔来艳, 等. 卡介菌及其衍生制品鉴别实验用BCG DNA国家参考品的研制. 中国药事, 2010,24(3):244-247. |
[18] |
赵爱华, 寇丽杰, 徐苗, 等. 我国皮内注射用卡介苗使用说明书修订意见. 中国防痨杂志, 2014,36(10):863-867. doi: 10.3969/j.issn.1000-6621.2014.10.001.
doi: 10.3969/j.issn.1000-6621.2014.10.001 |
[19] |
夏露, 卢水华, 李锋. 母牛分枝杆菌菌苗治疗卡介苗反应性淋巴结炎临床分析. 中国防痨杂志, 2016,38(3):189-192. doi: 10.3969/j.issn.1000-6621.2016.03.007.
doi: 10.3969/j.issn.1000-6621.2016.03.007 |
[20] |
Suliman OM, Ahmed MJ, Bilal JA. Clinical characteristics and needle aspiration management of Bacillus Calmette-Guérin lymphadenitis in children. Saudi Med J, 2015,36(3):280-285. doi: 10.15537/smj.2015.3.10294.
doi: 10.15537/smj.2015.3.10294 pmid: 25737168 |
[21] |
Kilic SS, Hacimustafaoglu M, Boisson-Dupuis S, et al. A patient with tyrosine kinase 2 deficiency without hyper-IgE syndrome. J Pediatr, 2012,160(6):1055-1057. doi: 10.1016/j.jpeds.2012.01.056.
doi: 10.1016/j.jpeds.2012.01.056 URL |
[22] |
Hatipoglu N, Güvenç BH, Deswarte C, et al. Inherited IL-12Rβ1 Deficiency in a Child With BCG Adenitis and Oral Candidiasis: A Case Report. Pediatrics, 2017,140(5):e20161668. doi: 10.1542/peds.2016-1668.
doi: 10.1542/peds.2016-1668 URL |
[23] |
Aelami MH, Alborzi A, Pouladfar G, et al. Post-Vaccination Disseminated Bacillus Calmette Guerin Infection Among Children in Southern Iran. Jundishapur J Microbiol, 2015,8(11):e25663. doi: 10.5812/jjm.25663.
doi: 10.5812/jjm.25663 |
[24] |
Roglic'S , Dickson D, Miše B, et al. Successful Treatment of Disseminated Bacillus Calmette-Guérin Disease in an HIV-Infected Child with a Linezolid-Containing Regimen. Case Rep Infect Dis, 2016,2016:1528981. doi: 10.1155/2016/1528981.
doi: 10.1155/2016/1528981 |
[25] |
中华医学会儿科学分会免疫学组, 《中华儿科杂志》编辑委员会. 原发性免疫缺陷病抗感染治疗与预防专家共识. 中华儿科杂志, 2017,55(4):248-255. doi: 10.3760/cma.j.issn.0578-1310.2017.04.003.
doi: 10.3760/cma.j.issn.0578-1310.2017.04.003 |
[26] |
Sriaroon P, Ballow M. Immunoglobulin Replacement Therapy for Primary Immunodeficiency. Immunol Allergy Clin North Am, 2015,35(4):713-730. doi: 10.1016/j.iac.2015.07.006.
doi: 10.1016/j.iac.2015.07.006 pmid: 26454315 |
[27] |
Wasserman RL. Personalized Therapy: Immunoglobulin Replacement for Antibody Deficiency. Immunol Allergy Clin North Am, 2019,39(1):95-111. doi: 10.1016/j.iac.2018.08.001.
doi: S0889-8561(18)30071-7 pmid: 30466775 |
[28] |
Lacerda-Pontes R, Gomes LN, Albuquerque RS, et al. The extended understanding of chronic granulomatous disease. Curr Opin Pediatr, 2019,31(6):869-873. doi: 10.1097/MOP.0000000000000830.
doi: 10.1097/MOP.0000000000000830 |
[29] |
Lum SH, Hoenig M, Gennery AR, et al. Conditioning Regimens for Hematopoietic Cell Transplantation in Primary Immunodeficiency. Curr Allergy Asthma Rep, 2019,19(11):52. doi: 10.1007/s11882-019-0883-1.
doi: 10.1007/s11882-019-0883-1 pmid: 31741098 |
[30] |
Shamriz O, Chandrakasan S. Update on Advances in Hematopoietic Cell Transplantation for Primary Immunodeficiency Disorders. Immunol Allergy Clin North Am, 2019,39(1):113-128. doi: 10.1016/j.iac.2018.08.003.
doi: S0889-8561(18)30073-0 pmid: 30466768 |
[31] |
Fernandes JF, Nichele S, Daudt LE, et al. Transplantation of Hematopoietic Stem Cells for Primary Immunodeficiencies in Brazil: Challenges in Treating Rare Diseases in Developing Countries. J Clin Immunol, 2018,38(8):917-926. doi: 10.1007/s10875-018-0564-1.
doi: 10.1007/s10875-018-0564-1 URL |
[32] |
Booth C, Romano R, Roncarolo MG, et al. Gene therapy for primary immunodeficiency. Hum Mol Genet, 2019,28(R1):R15-R23. doi: 10.1093/hmg/ddz170.
doi: 10.1093/hmg/ddz170 URL |
[33] |
Cavazzana M, Bushman FD, Miccio A, et al. Gene therapy targeting haematopoietic stem cells for inherited diseases: progress and challenges. Nat Rev Drug Discov, 2019,18(6):447-462. doi: 10.1038/s41573-019-0020-9.
doi: 10.1038/s41573-019-0020-9 pmid: 30858502 |
[34] |
肖桂荣, 张莹, 马晴, 等. 国内外结核病诊疗指南中关于抗结核药物相互作用管理的分析. 华西医学, 2015,30(5):954-958. doi: 10.7507/1002-0179.20150273.
doi: 10.7507/1002-0179.20150273 |
[35] |
Carneiro-Sampaio M, Jacob CM, Leone CR. A proposal of warning signs for primary immunodeficiencies in the first year of life. Pediatr Allergy Immunol, 2011,22(3):345-346. doi: 10.1111/j.1399-3038.2010.01084.x.
doi: 10.1111/j.1399-3038.2010.01084.x pmid: 21457340 |
[36] |
Thaventhiran JED, Lango Allen H, Burren OS, et al. Whole-genome sequencing of a sporadic primary immunodeficiency cohort. Nature, 2020,583(7814):90-95. doi: 10.1038/s41586-020-2265-1.
doi: 10.1038/s41586-020-2265-1 pmid: 32499645 |
[37] |
Seleman M, Hoyos-Bachiloglu R, Geha RS, et al. Uses of Next-Generation Sequencing Technologies for the Diagnosis of Primary Immunodeficiencies. Front Immunol, 2017,8:847. doi: 10.3389/fimmu.2017.00847.
doi: 10.3389/fimmu.2017.00847 URL |
[38] |
Kanegane H, Hoshino A, Okano T, et al. Flow cytometry-based diagnosis of primary immunodeficiency diseases. Allergol Int, 2018,67(1):43-54. doi: 10.1016/j.alit.2017.06.003.
doi: 10.1016/j.alit.2017.06.003 URL |
[39] |
Al-Hammadi S, Alsuwaidi AR, Alshamsi ET, et al. Disseminated Bacillus Calmette-Guérin (BCG) infections in infants with immunodeficiency. BMC Res Notes, 2017,10(1):177. doi: 10.1186/s13104-017-2499-7.
doi: 10.1186/s13104-017-2499-7 pmid: 28476145 |
[40] |
Alsuhaibani M, Felimban G, Shoukri M, et al. Safety and tolerability of moxifloxacin for the treatment of disseminated BCGitis in children. Int J Pediatr Adolesc Med, 2019,6(2):47-50. doi: 10.1016/j.ijpam.2019.01.003.
doi: 10.1016/j.ijpam.2019.01.003 URL |
[41] |
Marciano BE, Huang CY, Joshi G, et al. BCG vaccination in patients with severe combined immunodeficiency: complications, risks, and vaccination policies. J Allergy Clin Immunol, 2014,133(4):1134-1141. doi: 10.1016/j.jaci.2014.02.028.
doi: 10.1016/j.jaci.2014.02.028 URL |
[42] |
中国研究型医院学会泌尿外科学专业委员会, 中国医疗保健国际交流促进会泌尿健康促进分会, 中国医疗保健国际交流促进会循证医学分会, 等. 中国非肌层浸润性膀胱癌治疗与监测循证临床实践指南(2018年标准版). 现代泌尿外科杂志, 2019,24(7):516-542. doi: 10.3969/j.issn.1009-8291.2019.07.004.
doi: 10.3969/j.issn.1009-8291.2019.07.004 |
[43] |
Kaburaki K, Sugino K, Sekiya M, et al. Miliary Tuberculosis that Developed after Intravesical Bacillus Calmette-Guerin Therapy. Intern Med, 2017,56(12):1563-1567. doi: 10.2169/internalmedicine.56.8055.
doi: 10.2169/internalmedicine.56.8055 URL |
[44] |
Rachakonda T, Kendall B, Spivak AM, et al. Pleural Effusion Caused by Bacillus Calmette-Guérin Immunotherapy for Bladder Cancer. Open Forum Infect Dis, 2017, 4(3):ofx126. doi: 10.1093/ofid/ofx126.
doi: 10.1093/ofid/ofx126 |
[45] |
To U, Kim J, Chia D. Disseminated BCG: Complications of Intravesical Bladder Cancer Treatment. Case Rep Med, 2014,2014:362845. doi: 10.1155/2014/362845.
doi: 10.1155/2014/362845 |
[46] |
Golub V, Malhotra P, Patel S. Mycobacterial brain tuberculomas due to Bacille Calmette-Guérin intravesical chemotherapy for bladder cancer: A case report and literature review. Can J Infect Dis Med Microbiol, 2011,22(3):104-106. doi: 10.1155/2011/869286.
doi: 10.1155/2011/869286 URL |
[47] |
Pérez-Jacoiste Asín MA, Fernández-Ruiz M, López-Medrano F, et al. Bacillus Calmette-Guérin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature. Medicine (Baltimore), 2014,93(17):236-254. doi: 10.1097/MD.0000000000000119.
doi: 10.1097/MD.0000000000000119 pmid: 25398060 |
[1] | 陈卉, 张慧, 成君. 《中国学校结核病防控指南》解读[J]. 中国防痨杂志, 2021, 43(6): 542-545. |
[2] | 王元智, 梁正敏, 屈孟锦, 周向梅. 结核病疫苗及接种策略研究进展[J]. 中国防痨杂志, 2021, 43(6): 625-630. |
[3] | 冯莹, 任斐. 2019年南非《利福平耐药结核病管理临床指南》解读及与我国《耐药结核病化学治疗指南(2019年)》对比[J]. 中国防痨杂志, 2021, 43(3): 295-298. |
[4] | 中国防痨协会学术工作委员会《中国防痨杂志》编辑委员会. 抗结核药品固定剂量复合制剂的临床使用专家共识[J]. 中国防痨杂志, 2020, 42(9): 885-893. |
[5] | 赵爱华, 康万里, 王国治, 高正伦, 都伟欣, 卢锦标, 沈小兵, 苏城, 徐苗, 郑素华. 重组结核分枝杆菌11kDa蛋白鉴别潜伏性结核感染与卡介苗接种的研究[J]. 中国防痨杂志, 2020, 42(8): 821-825. |
[6] | 杨鲁琦, 沈鸣逸, 沙巍, 陈颖盈, 王颖. 卡介苗的免疫保护机制及其改造策略进展[J]. 中国防痨杂志, 2020, 42(8): 863-868. |
[7] | 陈柠, 孙琳, 申阿东, 何秋水. 卡介苗接种后发生感染的可能原因研究现况[J]. 中国防痨杂志, 2020, 42(8): 869-873. |
[8] | 谢莉, 高静韬, 马丽萍, 张立群, 孔忠顺, 吴晓光, 刘荣梅, 陈红梅, 宋艳华, 李雪莲, 黄麦玲, 李强, 吕子征, 刘宇红, 高孟秋. 含贝达喹啉方案治疗耐多药肺结核对患者心电图QT间期的影响[J]. 中国防痨杂志, 2020, 42(7): 687-694. |
[9] | 首都医科大学附属北京胸科医院中国防痨协会临床试验专业分会《中国防痨杂志》编辑委员会. 环丝氨酸治疗结核病的临床用药指南[J]. 中国防痨杂志, 2020, 42(6): 533-540. |
[10] | 黄国军, 高源, 唐细良, 高晓, 白丽琼. 胸腺五肽辅助治疗复治菌阳肺结核疗效和安全性的Meta分析[J]. 中国防痨杂志, 2020, 42(6): 570-577. |
[11] | 首都医科大学附属北京胸科医院, 中国防痨协会临床试验专业分会, 《中国防痨杂志》编辑委员会. 氯法齐明治疗结核病的临床应用指南[J]. 中国防痨杂志, 2020, 42(5): 409-417. |
[12] | 肖和平,刘一典. 新型冠状病毒肺炎疫情防控机制对结核病防治的启示[J]. 中国防痨杂志, 2020, 42(4): 311-315. |
[13] | 范琳,刘一典,肖和平. 国内《耐药结核病化学治疗指南(2019年)》与相关共识的特色及要点分析[J]. 中国防痨杂志, 2020, 42(2): 91-94. |
[14] | 李婷, 范云帆, 付英梅. 结核分枝杆菌细胞外RNA的研究现状[J]. 中国防痨杂志, 2020, 42(11): 1250-1253. |
[15] | 王泽明, 孙琳, 申阿东. 儿童结核病临床实践指南的现状与思考[J]. 中国防痨杂志, 2020, 42(10): 1025-1028. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||